ATOPIC DERMATITIS: NEW TARGETS OF THERAPY
Treatment of atopic dermatitis (AD) is most often based on the relief of symptoms. Two fundamental basis of AD — dry skin and itching — determine the main objectives of treatment of this chronic inflammatory diseases of the skin. With this purpose, the patients are recommended to use moisturizers (e...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2014-07-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/170 |
_version_ | 1797696916325138432 |
---|---|
author | D. Sh. Macharadze |
author_facet | D. Sh. Macharadze |
author_sort | D. Sh. Macharadze |
collection | DOAJ |
description | Treatment of atopic dermatitis (AD) is most often based on the relief of symptoms. Two fundamental basis of AD — dry skin and itching — determine the main objectives of treatment of this chronic inflammatory diseases of the skin. With this purpose, the patients are recommended to use moisturizers (emollients) and topical anti-inflammatory drugs — corticosteroids, and/or calcineurin inhibitors. However, there are studies conclusively proving the existence of subclinical inflammation associated with impaired barrier function ofthe skin, production of cytokines and infiltration of lymphocytes. The new strategy of treatment — proactive therapy aimed at achieving control and maintenance of remission of atopic dermatitis. This will allow you to achieve faster control the symptoms of AD and to reduce the risk of recurrence of the disease. |
first_indexed | 2024-03-12T03:32:56Z |
format | Article |
id | doaj.art-9285d75d849d4bbdaa091976185d379d |
institution | Directory Open Access Journal |
issn | 1682-5527 1682-5535 |
language | English |
last_indexed | 2024-03-12T03:32:56Z |
publishDate | 2014-07-01 |
publisher | "Paediatrician" Publishers LLC |
record_format | Article |
series | Вопросы современной педиатрии |
spelling | doaj.art-9285d75d849d4bbdaa091976185d379d2023-09-03T13:24:23Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352014-07-01134707310.15690/vsp.v13i4.1087170ATOPIC DERMATITIS: NEW TARGETS OF THERAPYD. Sh. Macharadze0Российский университет дружбы народов, МоскваTreatment of atopic dermatitis (AD) is most often based on the relief of symptoms. Two fundamental basis of AD — dry skin and itching — determine the main objectives of treatment of this chronic inflammatory diseases of the skin. With this purpose, the patients are recommended to use moisturizers (emollients) and topical anti-inflammatory drugs — corticosteroids, and/or calcineurin inhibitors. However, there are studies conclusively proving the existence of subclinical inflammation associated with impaired barrier function ofthe skin, production of cytokines and infiltration of lymphocytes. The new strategy of treatment — proactive therapy aimed at achieving control and maintenance of remission of atopic dermatitis. This will allow you to achieve faster control the symptoms of AD and to reduce the risk of recurrence of the disease.https://vsp.spr-journal.ru/jour/article/view/170детиатопический дерматитрецидивылечениетопические кортикостероиды |
spellingShingle | D. Sh. Macharadze ATOPIC DERMATITIS: NEW TARGETS OF THERAPY Вопросы современной педиатрии дети атопический дерматит рецидивы лечение топические кортикостероиды |
title | ATOPIC DERMATITIS: NEW TARGETS OF THERAPY |
title_full | ATOPIC DERMATITIS: NEW TARGETS OF THERAPY |
title_fullStr | ATOPIC DERMATITIS: NEW TARGETS OF THERAPY |
title_full_unstemmed | ATOPIC DERMATITIS: NEW TARGETS OF THERAPY |
title_short | ATOPIC DERMATITIS: NEW TARGETS OF THERAPY |
title_sort | atopic dermatitis new targets of therapy |
topic | дети атопический дерматит рецидивы лечение топические кортикостероиды |
url | https://vsp.spr-journal.ru/jour/article/view/170 |
work_keys_str_mv | AT dshmacharadze atopicdermatitisnewtargetsoftherapy |